Keith J. Petrie*
Generic drugs serve as a critical bridge between affordability and quality healthcare, offering cost-effective alternatives to brand-name medications without compromising safety or efficacy. This paper explores the role of generic drugs in healthcare, examining their economic, regulatory, and therapeutic implications. By analysing factors such as pricing dynamics, regulatory standards, and patient outcomes, this paper highlights how generic drugs contribute to expanding access to essential treatments while reducing healthcare costs. Through case studies and empirical evidence, it underscores the importance of leveraging generic drugs to bridge the gap between affordability and quality healthcare, ultimately improving patient outcomes and promoting healthcare sustainability.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 